Ventilator Hyperinflation and Hemodynamics
VHI-HD
Hemodynamic Repercussions of Ventilator Hyperinflation Using Volume-controlled Ventilation: a Randomized Controlled Trial
1 other identifier
interventional
17
1 country
1
Brief Summary
Ventilator hyperinflation (VHI) has been shown to be effective in improving respiratory mechanics, secretion removal, and gas exchange in mechanically ventilated patients; however, the literature is scarce concerning its safety and adverse effects. Thus, the aim of this study is to compare the hemodynamic repercussions of VHI in volume-controlled mode. In a randomized, controlled and crossover design, 24 mechanically ventilated patients will undergo 2 modes of ventilator hyperinflation (with and without an inspiratory pause) and a control intervention. Cardiac output, cardiac index, mean arterial pressure, pulmonary vascular resistance, systolic volume and other hemodynamic variables will be recorded during the interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 5, 2017
CompletedFirst Submitted
Initial submission to the registry
May 13, 2018
CompletedFirst Posted
Study publicly available on registry
June 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2018
CompletedAugust 14, 2020
August 1, 2020
11 months
May 13, 2018
August 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Cardiac Output
Estimation of cardiac output variation using thoracic bioimpedance
Baseline (before) and 10 minutes after the onset of VHI modesBasel
Secondary Outcomes (9)
Change in Cardiac Index
Baseline (before) and 10 minutes after the onset of VHI modes
Change in Vascular pulmonary resistance
Baseline (before) and 10 minutes after the onset of VHI modes
Change in Systolic Volume
Baseline (before) and 10 minutes after the onset of VHI modes
Change in Mean Arterial Pressure
Baseline (before) and 10 minutes after the onset of VHI modes
Change in Cardiac Output II
Baseline (before) and 5 minutes after the end of VHI modes
- +4 more secondary outcomes
Study Arms (3)
Baseline Mechanical Ventilation
SHAM COMPARATORThe subjects will be kept in Volume Control Continuous Mandatory Ventilation (VC-CMV) with an inspiratory flow = 60Lpm and tidal volume = 6mL/IBW. Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.
VHI With Inspiratory Pause
EXPERIMENTALApplication of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV). The inspiratory flow will be set at 20Lpm, the tidal volume will be increased in steps of 200mL until the peak airway pressure of 40cmH2O is achieved, and an inspiratory pause will be applied at the end of inspiration. After achieving the target pressure, this ventilatory regimen will last 15 minutes. Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.
VHI Without Inspiratory Pause
EXPERIMENTALApplication of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV). The inspiratory flow will be set at 20Lpm and the tidal volume will be increased in steps of 200mL until the peak airway pressure of 40cmH2O is achieved. After achieving the target pressure, this ventilatory regimen will last 15 minutes. Positive end-expiratory pressure and the inspired oxygen fraction will not be modified.
Interventions
The subjects will be kept in Volume Control Continuous Mandatory Ventilation (VC-CMV).
Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV) with an inspiratory pause.
Application of a ventilator hyperinflation intervention with Volume Control Continuous Mandatory Ventilation (VC-CMV) without an inspiratory pause.
Eligibility Criteria
You may qualify if:
- Patients under mechanical ventilation for more than 48h
You may not qualify if:
- mucus hypersecretion (defined as the need for suctioning \< 2-h intervals),
- absence of respiratory drive,
- atelectasis,
- severe bronchospasm,
- positive end expiratory pressure \> 10cmH2O,
- PaO2-FiO2 relationship \< 150,
- mean arterial pressure \< 60mmHg,
- inotrope requirement equivalent to \>15 ml/h total of adrenaline and noradrenalin,
- intracranial pressure \> 20mmHg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Santa Martha
Niterói, Rio de Janeiro, 24241-002, Brazil
Related Publications (3)
Berney S, Denehy L. A comparison of the effects of manual and ventilator hyperinflation on static lung compliance and sputum production in intubated and ventilated intensive care patients. Physiother Res Int. 2002;7(2):100-8. doi: 10.1002/pri.246.
PMID: 12109234RESULTLemes DA, Zin WA, Guimaraes FS. Hyperinflation using pressure support ventilation improves secretion clearance and respiratory mechanics in ventilated patients with pulmonary infection: a randomised crossover trial. Aust J Physiother. 2009;55(4):249-54. doi: 10.1016/s0004-9514(09)70004-2.
PMID: 19929767RESULTAnderson A, Alexanders J, Sinani C, Hayes S, Fogarty M. Effects of ventilator vs manual hyperinflation in adults receiving mechanical ventilation: a systematic review of randomised clinical trials. Physiotherapy. 2015 Jun;101(2):103-10. doi: 10.1016/j.physio.2014.07.006. Epub 2014 Oct 6.
PMID: 25453540RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Fernando Guimaraes, PhD
Centro Universitário Augusto Motta
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2018
First Posted
June 15, 2018
Study Start
November 5, 2017
Primary Completion
September 20, 2018
Study Completion
September 30, 2018
Last Updated
August 14, 2020
Record last verified: 2020-08